Stay updated on ADMEC-O: Clinical Trial of Immunotherapy vs Observation

Sign up to get notified when there's something new on the ADMEC-O: Clinical Trial of Immunotherapy vs Observation page.
Latest website image capture
Clouds background image

Latest updates to the ADMEC-O: Clinical Trial of Immunotherapy vs Observation page

  1. Check
    5 days ago
    Change Detected
    Summary
    No significant changes to the study details were detected; the page continues to present the ADMEC-O trial with nivolumab vs observation, including its design, endpoints, and eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:19:47.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Updated to v3.2.0 with a government operating-status notice; a resource entry (Cutaneous neuroendocrine carcinoma) was removed and revision tag shows v3.1.0 previously.
    Difference
    3%
    Check dated 2025-10-05T10:28:08.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:23:29.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Updated the revision to v3.0.2, replacing v3.0.1; Back to Top element removed. No other substantive content changes.
    Difference
    0.2%
    Check dated 2025-09-13T17:45:57.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-06T15:26:47.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as a detailed publication related to cutaneous neuroendocrine carcinoma, while several previous location terms and specific cancer types have been removed.
    Difference
    9%
    Check dated 2025-08-30T12:10:53.000Z thumbnail image

Stay in the know with updates to ADMEC-O: Clinical Trial of Immunotherapy vs Observation

Enter your email address, and we'll notify you when there's something new on the ADMEC-O: Clinical Trial of Immunotherapy vs Observation page.